NCT06486350View on ClinicalTrials.gov

IL-6: A Marker for AML Chemo Sensitivity

RecruitingOBSERVATIONAL

Enrollment

72

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

June 30, 2025

Conditions

AML, Adult

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors

lead

Fujian Medical University Union Hospital

OTHER